Validation of the BOADICEA Model in a Prospective Cohort of BRCA1/2 Pathogenic Variant Carriers

Xin Yang, Thea M. Mooij, Goska Leslie, Lorenzo Ficorella, Nadine Andrieu, Karin Kast, Christian F. Singer, Anna Jakubowska, Carla H. van Gils, Yen Tan, Christoph Engel, Muriel A. Adank, Christi J. van Asperen, Margreet G.E.M. Ausems, Pascaline Berthet, EMBRACE collaborators, J. Margriet Collée, Jackie Cook, Jacqueline Eason, K.Y. van Spaendonck-Zwarts, D Gareth Evans, Encarna B. Gomez Garcia, Helen Hanson, Louise Izatt, Zoe Kemp, Fiona Lalloo, Christine Lasset, Fabienne Lesueur, Hannah Musgrave, Sophie Nambot, Catherine Noguès, Jan C. Oosterwijk, Dominique Stoppa-Lyonnet, Marc Tischkowitz, Vishakha Tripathi, Marijke R. Wevers, Emily Zhao, Flora van Leeuwen, Marjanka K. Schmidt, Douglas F. Easton, Matti A. Rookus, Antonis C. Antoniou
doi: https://doi.org/10.1101/2024.04.21.24306136

Article Information

doi 
https://doi.org/10.1101/2024.04.21.24306136
History 
  • April 22, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Xin Yang1,*,
  2. Thea M. Mooij2,
  3. Goska Leslie1,
  4. Lorenzo Ficorella1,
  5. Nadine Andrieu3,4,5,6,
  6. Karin Kast7,
  7. Christian F. Singer8,
  8. Anna Jakubowska9,10,
  9. Carla H. van Gils11,
  10. Yen Tan8,
  11. Christoph Engel12,
  12. Muriel A. Adank13,
  13. Christi J. van Asperen14,
  14. Margreet G.E.M. Ausems15,
  15. Pascaline Berthet16,
  16. EMBRACE collaborators1,
  17. J. Margriet Collée17,
  18. Jackie Cook18,
  19. Jacqueline Eason19,
  20. K.Y. van Spaendonck-Zwarts20,
  21. D Gareth Evans21,22,23,
  22. Encarna B. Gomez Garcia24,
  23. Helen Hanson25,
  24. Louise Izatt26,
  25. Zoe Kemp27,
  26. Fiona Lalloo28,
  27. Christine Lasset29,30,31,
  28. Fabienne Lesueur3,4,5,6,
  29. Hannah Musgrave32,
  30. Sophie Nambot33,34,
  31. Catherine Noguès35,36,
  32. Jan C. Oosterwijk37,
  33. Dominique Stoppa-Lyonnet38,39,40,
  34. Marc Tischkowitz41,
  35. Vishakha Tripathi42,
  36. Marijke R. Wevers43,
  37. Emily Zhao1,
  38. Flora van Leeuwen2,
  39. Marjanka K. Schmidt14,44,
  40. Douglas F. Easton1,45,
  41. Matti A. Rookus2 and
  42. Antonis C. Antoniou1
  1. 1Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK
  2. 2Department of Epidemiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE Amsterdam, The Netherlands
  3. 3INSERM, U900, Paris, France
  4. 4Institut Curie, Paris, France
  5. 5Mines ParisTech, Fontainebleau, France
  6. 6PSL Research University, Paris, France
  7. 7Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Cologne, Germany
  8. 8Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
  9. 9Department of Genetics and Pathology, Pomeranian Medical University, Unii Lubelskiej 1, 71-252 Szczecin, Poland
  10. 10Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Unii Lubelskiej 1, 71-252 Szczecin, Poland
  11. 11Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, PO Box 85500, 3508 GA Utrecht, the Netherlands
  12. 12Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany
  13. 13Department of Clinical Genetics, The Netherlands Cancer Institute - Antoni van Leeuwenhoek hospital, Amsterdam 1066 CX, The Netherlands
  14. 14Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands
  15. 15Division Laboratories, Pharmacy and Biomedical Genetics, dept. of Genetics, University Medical Centre Utrecht, The Netherlands
  16. 16Centre François Baclesse, Oncogénétique Département de Biopathologie, Caen, France
  17. 17Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands
  18. 18Sheffield Clinical Genetics Service, Sheffield Children’s Hospital, Sheffield, UK
  19. 19Nottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Notingham, UK
  20. 20Department of Human Genetics, Amsterdam University Medical Centre, Meibergdreef 15, 1105AZ, Amsterdam, the Netherlands
  21. 21The Prevent Breast Cancer Research Unit, The Nightingale Centre, Manchester University NHS Foundation Trust, Manchester, M23 9LT, UK
  22. 22Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, St Mary’s Hospital, Manchester University NHS Foundation Trust, Oxford Road, Manchester, M13 9WL, UK
  23. 23Manchester Breast Centre, Oglesby Cancer Research Centre, The Christie, University of Manchester, 555 Wilmslow Rd., Manchester, M20 4GJ, UK
  24. 24Department Clinical Genetics, Maastricht University, The Netherlands
  25. 25South West Thames Regional Genetics Service, St George’s University Hospitals NHS Foundation Trust, London, UK
  26. 26Department of Clinical Genetics, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
  27. 27Department of Cancer Genetics, Royal Marsden Hospital, NHS Trust, London, England
  28. 28Clinical Genetics Service, Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
  29. 29Université Claude Bernard Lyon 1, Villeurbanne, France
  30. 30CNRS UMR 5558, Lyon, France
  31. 31Centre Léon Bérard, Unité de Prévention et Epidémiologie Génétique, Lyon, France
  32. 32Yorkshire Regional Genetics Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK
  33. 33Centre de Génétique et Centre de Référence Anomalies du Développement et Syndromes Malformatifs, CHU de Dijon, Hôpital d’Enfants, Dijon, France
  34. 34Centre de Lutte contre le Cancer Georges François Leclerc, Dijon, France
  35. 35Département d’Anticipation et de Suivi des Cancers, Oncogénétique Clinique, Institut Paoli Calmettes, Marseille, France
  36. 36Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France
  37. 37Department Genetics, University Medical Centre, University of Groningen, The Netherlands
  38. 38Institut Curie, Service de Génétique, Paris, France
  39. 39INSERM, U830, Paris, France
  40. 40Université de Paris, Paris, France
  41. 41Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK
  42. 42Clinical Genetics Service, Guy’s and St Thomas’ NHS Foundation Trust, London, UK
  43. 43Department Clinical Genetics, Radboud university medical center, The Netherlands
  44. 44Division of Molecular Pathology and Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, The Netherlands
  45. 45Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK
  1. ↵*Corresponding author Xin Yang, Centre for Cancer Genetic Epidemiology, University of Cambridge, Strangeways Research Laboratory, Worts Causeway, Cambridge, CB1 8RN, Tel: +44 (0)1223 761926, Email: xy249{at}medschl.cam.ac.uk
Back to top
Posted April 22, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Validation of the BOADICEA Model in a Prospective Cohort of BRCA1/2 Pathogenic Variant Carriers
Xin Yang, Thea M. Mooij, Goska Leslie, Lorenzo Ficorella, Nadine Andrieu, Karin Kast, Christian F. Singer, Anna Jakubowska, Carla H. van Gils, Yen Tan, Christoph Engel, Muriel A. Adank, Christi J. van Asperen, Margreet G.E.M. Ausems, Pascaline Berthet, EMBRACE collaborators, J. Margriet Collée, Jackie Cook, Jacqueline Eason, K.Y. van Spaendonck-Zwarts, D Gareth Evans, Encarna B. Gomez Garcia, Helen Hanson, Louise Izatt, Zoe Kemp, Fiona Lalloo, Christine Lasset, Fabienne Lesueur, Hannah Musgrave, Sophie Nambot, Catherine Noguès, Jan C. Oosterwijk, Dominique Stoppa-Lyonnet, Marc Tischkowitz, Vishakha Tripathi, Marijke R. Wevers, Emily Zhao, Flora van Leeuwen, Marjanka K. Schmidt, Douglas F. Easton, Matti A. Rookus, Antonis C. Antoniou
medRxiv 2024.04.21.24306136; doi: https://doi.org/10.1101/2024.04.21.24306136
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area